0.5470
+0.0320
+(6.21%)
As of 9:59:01 AM GMT+1. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
---|---|---|---|
ALEXANDRIA REAL ESTATE EQUITIES INC Beneficial Owner of more than 10% of a Class of Security | Sale | Jun 5, 2024 | -- |
FUNTLEYDER LESLIE D Chief Executive Officer | Stock Award(Grant) | Dec 19, 2024 | 427,911 |
HOOKS CORWIN DALE Officer | Stock Award(Grant) | Apr 12, 2024 | 300,000 |
JOHNSON JOHN H. Officer and Director | Stock Award(Grant) | Dec 19, 2024 | 500,000 |
KANTER STACY J Director | Stock Award(Grant) | Jun 6, 2024 | 108,000 |
LERNER TEENA L. PH.D. Director | Stock Award(Grant) | Jun 6, 2024 | 105,422 |
MARCUS JOEL S Director | Stock Award(Grant) | Jun 6, 2024 | 498,414 |
PERFETTI RICCARDO Officer | Sale | Aug 22, 2024 | 986,853 |
SHENDELMAN SHOSHANA Chief Executive Officer | Sale | Aug 14, 2024 | 7,309,500 |
SKYLER JAY S Director | Stock Award(Grant) | Jun 6, 2024 | 65,000 |
Related Tickers
AT20.F Atara Biotherapeutics, Inc.
8.05
+8.05%
NV4.F Cellectar Biosciences, Inc.
0.2160
+8.00%
M55.F MacroGenics, Inc.
2.8800
-0.48%
8AW0.F Ocean Biomedical, Inc.
0.1710
-22.27%
3G0.BE Altimmune Inc
6.76
+0.67%
0M4.DU Mersana Therapeutics Inc
0.6000
+1.59%
8AW0.BE Ocean Biomedical Inc
0.1900
+4.97%
1VT.DU Viking Therapeutics Inc
32.65
+1.56%
BX2.BE BioXcel Therapeutics Inc
0.3046
-2.09%
3G0.DU Altimmune Inc
6.62
-0.78%